- Home
- AEYE vs SCPH Comparison
AEYE vs SCPH Comparison
Compare AEYE & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AEYE
- SCPH
- Stock Information
- Founded
- AEYE 2005
- SCPH 2013
- Country
- AEYE United States
- SCPH United States
- Employees
- AEYE N/A
- SCPH N/A
- Industry
- AEYE Computer Software: Prepackaged Software
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- AEYE Technology
- SCPH Health Care
- Exchange
- AEYE Nasdaq
- SCPH Nasdaq
- Market Cap
- AEYE 278.0M
- SCPH 274.7M
- IPO Year
- AEYE N/A
- SCPH 2017
- Fundamental
- Price
- AEYE $25.51
- SCPH $3.46
- Analyst Decision
- AEYE Strong Buy
- SCPH Strong Buy
- Analyst Count
- AEYE 4
- SCPH 2
- Target Price
- AEYE $30.13
- SCPH $15.00
- AVG Volume (30 Days)
- AEYE 221.5K
- SCPH 470.9K
- Earning Date
- AEYE 11-07-2024
- SCPH 11-13-2024
- Dividend Yield
- AEYE N/A
- SCPH N/A
- EPS Growth
- AEYE N/A
- SCPH N/A
- EPS
- AEYE N/A
- SCPH N/A
- Revenue
- AEYE $33,348,000.00
- SCPH $30,278,000.00
- Revenue This Year
- AEYE $13.79
- SCPH $195.62
- Revenue Next Year
- AEYE $18.88
- SCPH $145.07
- P/E Ratio
- AEYE N/A
- SCPH N/A
- Revenue Growth
- AEYE 6.94
- SCPH 303.87
- 52 Week Low
- AEYE $3.97
- SCPH $3.08
- 52 Week High
- AEYE $34.85
- SCPH $6.71
- Technical
- Relative Strength Index (RSI)
- AEYE 50.81
- SCPH 30.73
- Support Level
- AEYE $23.99
- SCPH $4.00
- Resistance Level
- AEYE $34.85
- SCPH $4.60
- Average True Range (ATR)
- AEYE 2.50
- SCPH 0.23
- MACD
- AEYE 0.15
- SCPH -0.07
- Stochastic Oscillator
- AEYE 32.76
- SCPH 25.25
About AEYE AudioEye Inc.
AudioEye Inc is a software solution provider delivering immediate ADA and WCAG accessibility compliance at scale. Through patented technology, subject matter expertise and proprietary processes, it is eradicating all barriers to digital accessibility, helping creators get accessible and supporting them with ongoing advisory and automated upkeep. Trusted by the ADP, Tommy Hilfiger, A360 Media, Samsung, Landry's, and others. It helps everyone identify and resolve issues of accessibility and enhance user experiences, automating digital accessibility for the widest audiences.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.